We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 515

Genetic technologies settles infringement suit over non-DNA coding technology

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

Genetic Technologies Ltd. (GTG) has reportedly settled a patent infringement lawsuit filed in late 2012 against PreventionGenetics. While the terms

Biopharmaceuticals to collaborate on cancer drug discovery

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

FORMA Therapeutics Holdings, LLC has reportedly entered a strategic collaboration agreement with Celgene Corp. to discover, develop and commercialize

NASA tests plant-based biofuel in jets

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

National Aeronautics and Space Administration (NASA) researchers recently concluded a series of test flights in California to study the effects of

House appropriators concerned about sequestration of FDA user fees

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

Food and Drug Administration (FDA) Commissioner Margaret Hamburg reportedly testified before a House Appropriations Subcommittee about the effects of

News Bytes - May 2, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

The National Nanotechnology Coordination Office schedules a June 11-12, 2013, public workshop in Washington, D.C., "to obtain input from stakeholders

Federal Circuit addresses pleading standards for patent infringement claims

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

The Federal Circuit Court of Appeals has determined that a federal district court erred by relying on an incorrect pleading standard in dismissing

U.S. Senators propose subjecting compounded drugs to federal regulation

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

Bipartisan Senate health committee leaders have released draft legislation that would give the Food and Drug Administration (FDA) greater oversight

Michigan Biotech raises $33 million for clinical trials of small molecule therapies

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

Ann Arbor-based Esperion Therapeutics, Inc. has reportedly completed a $33-million preferred stock financing that CEO Tim Mayleben said will allow

Biotech secures $5.3 million for immunosuppressant drug research

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 18 2013

San Francisco-based startup, Nurix, Inc., which reportedly develops T-cellspecific immunosuppressants used to treat autoimmune diseases such as

VC, private financing still hard to find for OmicsMDx firms

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 18 2013

Companies developing diagnostics (MDx) and "omics" technologies (e.g., genomics, epigenomics, proteomics, metabolomics), used as predictors of

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy